Medical Press Release - Page 11 of 12 - Medika Life : Keeping you informed

A true glimpse into the process of transitioning a practice and how it can be a great solution to the issues facing private practices. Many are struggling,

Dental Surgical Equipment Market 2020-2024

Medika Life - March 24, 2021

A report on the Dental Surgical Market 2020-2024 by Technavia. The dental surgical equipment market is expected to grow by USD 1.42 billion during 2020-2024, expanding at a CAGR of almost 6%

Zero-Contact Medical Station for Safe and Rapid PCR Covid-19 Testing

Medika Life - May 6, 2021

Zero Contact Rapid PCR Testing. The biggest risk of infection for medical staff is during intubation, nasal swabbing, and personal protective equipment (PPE) removal

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life - August 12, 2020

SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

StuffThatWorks and The Marfan Foundation to Engage in Pilot Program

Intellihealth Chief Medical Officer, Dr. Leon Igel, Honored as American Diabetes Association Greater New York Research Dinner Medical Honoree of the Year

LATEST

TRENDING

Medika’s Call for Food Aid for Starving Filipino Children

Lover, the App That Helps Women Reach Orgasm

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

The 50 Most Influential Leaders in Pharmacy 2022 Awards

The Nation’s Only Virtual At-Home Detox Programs from Workit Health Expands

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

FINN Partners Brings Aboard the Pharmacy Podcast Network

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

South University Announces New MSPA Program at West Palm Beach Campus

Parnell Pharmaceuticals Announces Nomovid™ Antiviral Nasal Spray

EDITORS CHOICE

Private Practice: Solution Mode to Survival Mode

Dental Surgical Equipment Market 2020-2024

Zero-Contact Medical Station for Safe and Rapid PCR Covid-19 Testing

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories